Hanmi Science (008930) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hanmi Science (008930) has a cash flow conversion efficiency ratio of 0.008x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩7.96 Billion ≈ $5.39 Million USD) by net assets (₩1.00 Trillion ≈ $677.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hanmi Science (008930) balance sheet quality index to measure how much of total assets are equity-financed.
Hanmi Science - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Hanmi Science's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 008930 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Hanmi Science Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hanmi Science ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Scientech Corp
TW:3583
|
0.055x |
|
Shenzhen Batian Ecotypic Engineering Co Ltd
SHE:002170
|
0.028x |
|
Fortress Income Fund Ltd
JSE:FFB
|
0.032x |
|
Shanxi Zhangze Electric Power Co Ltd
SHE:000767
|
0.120x |
|
Shanghai Anlogic Infotech Co Ltd
SHG:688107
|
-0.029x |
|
GIMV NV
BR:GIMB
|
-0.120x |
|
Blackline Inc
NASDAQ:BL
|
0.137x |
|
Grupo Televisa SAB ADR
NYSE:TV
|
0.029x |
Annual Cash Flow Conversion Efficiency for Hanmi Science (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hanmi Science from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see Hanmi Science stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩959.19 Billion ≈ $650.03 Million |
₩47.66 Billion ≈ $32.30 Million |
0.050x | -49.79% |
| 2024-12-31 | ₩838.70 Billion ≈ $568.38 Million |
₩82.99 Billion ≈ $56.24 Million |
0.099x | +121.62% |
| 2023-12-31 | ₩787.47 Billion ≈ $533.66 Million |
₩35.16 Billion ≈ $23.83 Million |
0.045x | +242.35% |
| 2022-12-31 | ₩724.75 Billion ≈ $491.15 Million |
₩9.45 Billion ≈ $6.41 Million |
0.013x | -34.24% |
| 2021-12-31 | ₩690.29 Billion ≈ $467.80 Million |
₩13.69 Billion ≈ $9.28 Million |
0.020x | -5.45% |
| 2020-12-31 | ₩658.73 Billion ≈ $446.41 Million |
₩13.82 Billion ≈ $9.36 Million |
0.021x | +3.99% |
| 2019-12-31 | ₩645.69 Billion ≈ $437.57 Million |
₩13.02 Billion ≈ $8.83 Million |
0.020x | +387.66% |
| 2018-12-31 | ₩653.09 Billion ≈ $442.59 Million |
₩2.70 Billion ≈ $1.83 Million |
0.004x | +108.17% |
| 2017-12-31 | ₩665.15 Billion ≈ $450.76 Million |
₩-33.68 Billion ≈ $-22.83 Million |
-0.051x | -142.85% |
| 2016-12-31 | ₩647.56 Billion ≈ $438.84 Million |
₩76.52 Billion ≈ $51.86 Million |
0.118x | +47.12% |
| 2015-12-31 | ₩584.25 Billion ≈ $395.94 Million |
₩46.93 Billion ≈ $31.80 Million |
0.080x | +539.61% |
| 2014-12-31 | ₩417.71 Billion ≈ $283.08 Million |
₩5.25 Billion ≈ $3.55 Million |
0.013x | +2287.90% |
| 2013-12-31 | ₩409.07 Billion ≈ $277.22 Million |
₩-234.79 Million ≈ $-159.11K |
-0.001x | -100.95% |
| 2010-12-31 | ₩604.83 Billion ≈ $409.88 Million |
₩36.49 Billion ≈ $24.73 Million |
0.060x | -55.95% |
| 2009-12-31 | ₩444.88 Billion ≈ $301.49 Million |
₩60.93 Billion ≈ $41.29 Million |
0.137x | +31.54% |
| 2008-12-31 | ₩393.00 Billion ≈ $266.33 Million |
₩40.92 Billion ≈ $27.73 Million |
0.104x | -48.66% |
| 2006-12-31 | ₩291.16 Billion ≈ $197.32 Million |
₩59.05 Billion ≈ $40.02 Million |
0.203x | -4.83% |
| 2005-12-31 | ₩219.66 Billion ≈ $148.86 Million |
₩46.81 Billion ≈ $31.72 Million |
0.213x | +53.31% |
| 2004-12-31 | ₩181.81 Billion ≈ $123.21 Million |
₩25.27 Billion ≈ $17.13 Million |
0.139x | -4.75% |
| 2003-12-31 | ₩155.62 Billion ≈ $105.46 Million |
₩22.71 Billion ≈ $15.39 Million |
0.146x | -34.08% |
| 2002-12-31 | ₩146.43 Billion ≈ $99.23 Million |
₩32.42 Billion ≈ $21.97 Million |
0.221x | -22.75% |
| 2001-12-31 | ₩131.69 Billion ≈ $89.25 Million |
₩37.74 Billion ≈ $25.58 Million |
0.287x | +39.40% |
| 2000-12-31 | ₩90.93 Billion ≈ $61.62 Million |
₩18.69 Billion ≈ $12.67 Million |
0.206x | -- |
About Hanmi Science
Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more